
Vivian M Abascal, MD
Cardiovascular Disease (Heart Disease), Cardiology (Heart)
About Me
Vivian M. Abascal, M.D., has been appointed Assistant Clinical Professor of Medicine (Cardiology). Formerly Assistant Professor of Medicine, Clinical Series Track, at the University of Kentucky Medical Center, Dr. Abascal was also Co-director of the Cardiovascular Women's Health Clinic in the Gill Heart Institute at the University of Kentucky, and Co-director of the Heart Station and Echocardiography Laboratory at the Veterans Administration Medical Center in Kentucky. She received her medical degree from the Universidad Central de Venezuela, Caracas, and completed several clinical and research fellowships in medicine, cardiology, and cardiovascular epidemiology at Harvard Medical School and Boston University Medical School. She specializes in topics related to women and heart disease and to echocardiography.
Dr. Abascal and her colleagues at the Massachusetts General Hospital, Harvard Medical School were the first to develop an echocardiographic score to predict a successful outcome of percutaneous balloon valvuloplasty, therefore facilitating patient selection. The results of these projects were presented in national and international meetings and were published in major cardiology journals such as Circulation and the Journal of the American College of Cardiology.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Vivian M. Abascal, M.D., has been appointed Assistant Clinical Professor of Medicine (Cardiology). Formerly Assistant Professor of Medicine, Clinical Series Track, at the University of Kentucky Medical Center, Dr. Abascal was also Co-director of the Cardiovascular Women's Health Clinic in the Gill Heart Institute at the University of Kentucky, and Co-director of the Heart Station and Echocardiography Laboratory at the Veterans Administration Medical Center in Kentucky. She received her medical degree from the Universidad Central de Venezuela, Caracas, and completed several clinical and research fellowships in medicine, cardiology, and cardiovascular epidemiology at Harvard Medical School and Boston University Medical School. She specializes in topics related to women and heart disease and to echocardiography.
Dr. Abascal and her colleagues at the Massachusetts General Hospital, Harvard Medical School were the first to develop an echocardiographic score to predict a successful outcome of percutaneous balloon valvuloplasty, therefore facilitating patient selection. The results of these projects were presented in national and international meetings and were published in major cardiology journals such as Circulation and the Journal of the American College of Cardiology.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Annual Physical
- Aortic Disease
- Arrhythmia Diagnostic
- Cardiology Second Opinion
- Cardiomyopathy
- Cardiovascular Distress
- Chest Pain
- Cholesterol management
- ECG / EKG
Show More
Education
MD, Universidad Central de Venezuela
Internship, Internal Medicine
UMass Memorial Medical Center-University Campus
Residency, Cardiology
Boston University Medical Center
Certifications
American Board of Internal Medicine
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Mount Sinai Fuster Heart521 West 181st St, New York, NY, 10033
- Michael Correa MD1302 Amsterdam Avenue, New York, NY, 10027
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes. Maeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, Carlos G. Santos-Gallego, M. Urooj Zafar, Ginés Escolar, Donna Mancini, Sumeet Mitter, David Lam, Johanna P. Contreras, Icilma Fergus, Farah Atallah-Lajam, Vivian Abascal, Anu Lala, Pedro Moreno, Noah Moss, Stamatios Lerakis, Javier Sanz, Valentin Fuster, Juan José Badimon. Cardiovascular Drugs and Therapy
- Cardiac tumors: Updated classifications and main clinico-pathologic findings. Domenico Corradi, Pedro R. Moreno, Mohamed Rahouma, Vivian M. Abascal, Debora Guareschi, Alessandro Tafuni, Valentina Grazioli, Alessandro Palumbo, Giampaolo Niccoli, Roberto Lorusso. Trends in Cardiovascular Medicine
- Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction. Carlos G. Santos-Gallego, Ariana P. Vargas-Delgado, Juan Antonio Requena-Ibanez, Alvaro Garcia-Ropero, Donna Mancini, Sean Pinney, Frank Macaluso, Samantha Sartori, Merce Roque, Fernando Sabatel-Perez, Anderly Rodriguez-Cordero, M. Urooj Zafar, Icilma Fergus, Farah Atallah-Lajam, Johanna P. Contreras, Cathleen Varley, Pedro R. Moreno, Vivian M. Abascal, Anuradha Lala, Ronald Tamler, Javier Sanz, Valentin Fuster, Juan J. Badimon. Journal of the American College of Cardiology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Abascal has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Abascal has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.